Michel Kalamarides

7.4k total citations · 1 hit paper
154 papers, 3.4k citations indexed

About

Michel Kalamarides is a scholar working on Epidemiology, Neurology and Surgery. According to data from OpenAlex, Michel Kalamarides has authored 154 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Epidemiology, 109 papers in Neurology and 36 papers in Surgery. Recurrent topics in Michel Kalamarides's work include Meningioma and schwannoma management (114 papers), Neurofibromatosis and Schwannoma Cases (88 papers) and Facial Nerve Paralysis Treatment and Research (29 papers). Michel Kalamarides is often cited by papers focused on Meningioma and schwannoma management (114 papers), Neurofibromatosis and Schwannoma Cases (88 papers) and Facial Nerve Paralysis Treatment and Research (29 papers). Michel Kalamarides collaborates with scholars based in France, United States and China. Michel Kalamarides's co-authors include Matthieu Peyre, Olivier Sterkers, Stéphane Goutagny, Marco Giovannini, Alexis Bozorg Grayeli, Caroline Apra, Danièle Bernardeschi, Michiko Niwa‐Kawakita, D. Bouccara and A. Rey and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Michel Kalamarides

145 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Conserved meningeal lymphatic drainage circuits in mice and humans

2022 98 citations Laurent Jacob, José M. Brito et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by Michel Kalamarides

Since Specialization

Citations

This map shows the geographic impact of Michel Kalamarides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Kalamarides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Kalamarides more than expected).

Fields of papers citing papers by Michel Kalamarides

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Kalamarides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Kalamarides. The network helps show where Michel Kalamarides may publish in the future.

Co-authorship network of co-authors of Michel Kalamarides

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Kalamarides. A scholar is included among the top collaborators of Michel Kalamarides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Kalamarides. Michel Kalamarides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Specific Methylation Class Identifies BAP1‐Deficient Meningiomas, Including Meningeal Tumours With Poorly Differentiated Nonrhabdoid Histology 2025 ·Neuropathology and Applied Neurobiology ·(unknown), Mehdi Touat, Patrick R. Benusiglio, Philipp Euskirchen, Florence Coulet, (unknown), Arnaud de la Fouchardière, Vincent de Montpréville, (unknown), Danièle Bernardeschi, Pierre Laurent‐Puig, Marc Sanson, Michel Kalamarides, Franck Bielle	1
2	Cochlear Implantation in Neurofibromatosis Type 2‐Related Schwannomatosis: Long‐Term Hearing Outcomes 2024 ·Otolaryngology ·(unknown), Isabelle Mosnier, Évelyne Ferrary, Yann Nguyen, Olivier Sterkers, Michel Kalamarides, Ghizlène Lahlou, (unknown)	1
3	The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis 2023 ·Neuro-Oncology Advances ·(unknown), Abdurrahman I. Islim, Cathal John Hannan, (unknown), Charlotte Hammerbeck-Ward, Scott Rutherford, Simon Freeman, Simon Lloyd, Michel Kalamarides, Miriam J. Smith, Kevin N. Couper, Catherine McBain, Michael D. Jenkinson, David Brough, Andrew T. King, D. Gareth Evans, Omar Pathmanaban	5
4	Monitoring Cochlear Nerve Action Potential for Hearing Preservation in Medium/Large Vestibular Schwannoma Surgery: Tips and Pitfalls 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), Yann Nguyen, (unknown), Olivier Sterkers, Ghizlène Lahlou, Michel Kalamarides	3
5	Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2 2023 ·Neuro-Oncology Advances ·Justin T. Jordan, (unknown), (unknown), (unknown), Roberta L. Beauchamp, (unknown), Alona Muzikansky, Anat Stemmer‐Rachamimov, Marco Giovannini, Michel Kalamarides, Fred G. Barker, Vijaya Ramesh, Scott R. Plotkin	10
6	ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis 2022 ·European Journal of Human Genetics ·D. Gareth Evans, (unknown), David Pang, (unknown), (unknown), Nicolas Champollion, P. Wolkenstein, Nick Thomas, Rosalie E. Ferner, Michel Kalamarides, Matthieu Peyre, Laura Papi, Eric Legius, Juan Luís Becerra, Andrew T. King, Chris Duff, Stavros Stivaros, Ignacio Blanco	16
7	Conserved meningeal lymphatic drainage circuits in mice and humans breakdown → 2022 ·The Journal of Experimental Medicine ·Laurent Jacob, José M. Brito, Stéphanie Lenck, (unknown), (unknown), Luiz Henrique Geraldo, Yunling Xu, (unknown), (unknown), (unknown), Marie‐Claude Potier, Stéphane Haı̈k, Michel Kalamarides, Bruno Stankoff, Stéphane Lehéricy, Anne Eichmann, Jean‐Léon Thomas	98
8	LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL 2022 ·Cancer Discovery ·Aram Ko, Mohammad Hasanain, Young Taek Oh, Fulvio D’Angelo, (unknown), Brulinda Frangaj, (unknown), Franck Bielle, Bianca Pollo, Rosina Paterra, Karima Mokhtari, Rajesh K. Soni, Matthieu Peyre, Marica Eoli, Laura Papi, Michel Kalamarides, Marc Sanson, Antonio Iavarone, Anna Lasorella	13
9	GAB1 overexpression identifies hedgehog‐activated anterior skull base meningiomas 2021 ·Neuropathology and Applied Neurobiology ·Julien Boetto, (unknown), Matthieu Peyre, (unknown), (unknown), Michel Kalamarides, Franck Bielle	6
10	Hearing recovery after surgical resection of non-vestibular schwannoma cerebellopontine angle tumors 2021 ·European Archives of Oto-Rhino-Laryngology ·(unknown), (unknown), Michel Kalamarides, Danièle Bernardeschi, Olivier Sterkers, (unknown), (unknown), Nadya Pyatigorskaya, Ghizlène Lahlou	5
11	Isolated Bilateral Hypoglossal Palsy Complicating a Fourth Ventricle Ependymoma Surgery 2020 ·World Neurosurgery ·(unknown), (unknown), Michel Kalamarides	1
12	Current Management of Large Vestibular Schwannomas for NF2 Patients in a National Reference Center 2020 ·The Laryngoscope ·(unknown), Matthieu Peyre, Marc Sanson, Olivier Sterkers, Danièle Bernardeschi, Michel Kalamarides	4
13	Improving facial nerve outcome and hearing preservation by different degrees of vestibular schwannoma resection guided by intraoperative facial nerve electromyography 2020 ·Acta Neurochirurgica ·(unknown), Ghizlène Lahlou, Vincent Degos, Olivier Sterkers, Yann Nguyen, Michel Kalamarides	18
14	Metachronous Bilateral Vestibular Schwannomas 2020 ·The Laryngoscope ·(unknown), (unknown), Renato Torres, Olivier Sterkers, Yann Nguyen, Ghizlène Lahlou, Michel Kalamarides	1
15	How to radiologically identify a spontaneous regression of sporadic vestibular schwannoma? 2019 ·PLoS ONE ·Ghizlène Lahlou, M. Rodallec, Yann Nguyen, Olivier Sterkers, Michel Kalamarides	10
16	Spontaneously Resolving Symptomatic Subdural Hygromas After Cerebellopontine Angle Tumor Surgery 2017 ·World Neurosurgery ·(unknown), (unknown), Danièle Bernardeschi, Michel Kalamarides	0
17	Endothelial Cell Hypertrophy and Microvascular Proliferation in Meningiomas Are Correlated with Higher Histological Grade and Shorter Progression-Free Survival 2016 ·Journal of Neuropathology & Experimental Neurology ·(unknown), Celso Pouget, Fabien Rech, (unknown), (unknown), Franck Bielle, Karima Mokhtari, (unknown), Jean-Michel Vignaud, Michel Kalamarides, Matthieu Peyre, Guillaume Gauchotte	18
18	Genomic Profiling Reveals Alternative Genetic Pathways of Meningioma Malignant Progression Dependent on the Underlying NF2 Status 2010 ·Clinical Cancer Research ·Stéphane Goutagny, Hong Yang, Jessica Zucman‐Rossi, Jennifer A. Chan, Jonathan M. Dreyfuss, Peter J. Park, Peter McLaren Black, Marco Giovannini, Rona S. Carroll, Michel Kalamarides	84
19	Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas 2008 ·Oncogene ·Dominique Lallemand, Jan Manent, Anne Couvelard, Aurélie Watilliaux, M Siena, Fabrice Chareyre, (unknown), Michiko Niwa‐Kawakita, Michel Kalamarides, Marco Giovannini	98
20	[Acoustic neuromas and serviceable hearing: choosing the surgical approach]. 2002 ·PubMed ·A. Bozorg–Grayeli, Michel Kalamarides, (unknown), D. Bouccara, Rey A, Olivier Sterkers	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact